Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction.
Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses.
Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis.
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
Mutation Rate Variation is a Primary Determinant of the Distribution of Allele Frequencies in Humans.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutation Rate Variation is a Primary Determinant of the Distribution of Allele Frequencies in Humans.
Mutation Rate Variation is a Primary Determinant of the Distribution of Allele Frequencies in Humans. PLoS Genet. 2016 Dec; 12(12):e1006489.
View in:
PubMed
subject areas
Alleles
Amino Acid Substitution
Animals
Base Sequence
Chromosome Mapping
DNA Methylation
Exome
Gene Frequency
Genetics, Population
Humans
Mutation
Mutation Rate
Phylogeny
Pongo
Primates
Selection, Genetic
authors with profiles
Jonathan K. Pritchard